Key result
Screening by DLCN score and maximum LDL-C level showed no difference in predicting monogenic familial hypercholesterolemia, with monogenic etiologies found in 77% of pediatric patients.
Why the study?
Familial hypercholesterolemia is underdiagnosed and undertreated despite being the most common genetic disorder linked to premature atherosclerotic cardiovascular disease.
Observational (n=147)
Answers are grounded in this paper and cite their sources.
Either metric may suffice for monogenic FH stratification; leaves open optimal pediatric screening pending prospective validation.
BACKGROUND: Familial hypercholesterolemia (FH) is the most common genetic disorder associated with a high risk for premature atherosclerotic cardiovascular disease attributable to increased levels of LDL-cholesterol (LDL-C) from birth. FH is both underdiagnosed and undertreated. OBJECTIVE: We describe the clinical, biological, and genetic characteristics of 147 patients in France with clinical FH (including a group of 26 subjects aged < 20 years); we explore how best to detect patients with monogenic FH. METHODS: We retrospectively reviewed all available data on patients undergoing genetic tests for FH from 2009 to 2019. FH diagnoses were based on the Dutch Lipid Clinics Network (DLCN) scores of adults, and elevated LDL-C levels in subjects < 20 years of age. We evaluated LDLR, APOB, and PCSK9 status. RESULTS: The mutations of adults (in 25.6% of all adults) were associated with DLCN scores indicating "possible FH," "probable FH, and "definitive FH" at rates of 4%, 16%, and 53%, respectively. The areas under the ROC curves of the DLCN score and the maximum LDL-C level did not differ (p = 0.32). We found that the pediatric group evidenced more monogenic etiologies (77%, increasing to 91% when an elevated LDL-C level was combined with a family history of hypercholesterolemia and/or premature coronary artery disease). CONCLUSION: Diagnosis of monogenic FH may be optimized by screening children in terms of their LDL-C levels, associated with reverse-cascade screening of relatives when the children serve as index cases.
No takes yet. Share an insight, caveat, or question.
Fourgeaud et al. (2022) conducted an observational in Familial hypercholesterolemia (n=147). DLCN score and maximum LDL-C level evaluation was evaluated on Detection of monogenic familial hypercholesterolemia via area under the ROC curves (p=0.32). Screening by DLCN score and maximum LDL-C level showed no difference in predicting monogenic familial hypercholesterolemia, with monogenic etiologies found in 77% of pediatric patients.
Synapse has enriched 10 related papers. Consider them for comparative context: